Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Alphatec Holdings Inc (ATEC) Insider Trading Activity
Healthcare • Medical Devices • 839 employees
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Total Value
-$4,050,050.42
Total Shares
2,021,072
Average Trade Value
-$106,580.27
Most Active Insider
Miles Patrick
Total Activity: $2,728,134
Largest Single Transaction
$624,211
by Sponsel David on Jan 13, 2025
30-Day Activity
24 Transactions
Volume: 1,917,002 shares
Value: $2,451,613
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
Chief Operating Officer
|
Feb 6, 2025 | 27,453 | $315,435 | 867,677 (-3.2%) | Sale | |
CEO
|
Feb 5, 2025 | 43,459 | $519,335 | 6,065,772 (-0.7%) | Sale | |
Evp, Sales
|
Feb 3, 2025 | 36,256 | $414,044 | 735,074 (-4.9%) | Sale | |
CEO
|
Jan 30, 2025 | 43,313 | $521,055 | 6,109,231 (-0.7%) | Sale | |
Evp, People Culture
|
Jan 29, 2025 | 173,417 | $0 | 1,606,558 (+10.8%) | Grant | |
Chief Operating Officer
|
Jan 29, 2025 | 19,900 | $0 | 895,130 (+2.2%) | Grant | |
Evp, Sales
|
Jan 29, 2025 | 114,322 | $0 | 750,224 (+15.2%) | Grant | |
CEO
|
Jan 29, 2025 | 311,634 | $0 | 5,813,349 (+5.4%) | Grant | |
Chief Financial Officer
|
Jan 29, 2025 | 120,952 | $0 | 514,308 (+23.5%) | Grant | |
Evp, Sales
|
Jan 29, 2025 | 133,591 | $0 | 635,902 (+21.0%) | Grant | |
Chief Financial Officer
|
Jan 29, 2025 | 114,322 | $0 | 628,630 (+18.2%) | Grant | |
Evp, People Culture
|
Jan 29, 2025 | 156,935 | $0 | 1,433,141 (+11.0%) | Grant | |
CEO
|
Jan 29, 2025 | 48,240 | $0 | 6,202,544 (+0.8%) | Grant | |
Evp, People Culture
|
Jan 29, 2025 | 21,709 | $0 | 1,628,267 (+1.3%) | Grant | |
CEO
|
Jan 29, 2025 | 340,955 | $0 | 6,154,304 (+5.5%) | Grant | |
CEO
|
Jan 29, 2025 | 50,000 | $601,500 | 6,152,544 (-0.8%) | Sale | |
Chief Operating Officer
|
Jan 29, 2025 | 120,952 | $0 | 701,813 (+17.2%) | Grant | |
Chief Operating Officer
|
Jan 29, 2025 | 173,417 | $0 | 875,230 (+19.8%) | Grant | |
General Counsel Corp. Sec.
|
Jan 29, 2025 | 12,965 | $0 | 478,758 (+2.7%) | Grant | |
General Counsel Corp. Sec.
|
Jan 29, 2025 | 105,833 | $0 | 351,471 (+30.1%) | Grant | |
General Counsel Corp. Sec.
|
Jan 29, 2025 | 114,322 | $0 | 465,793 (+24.5%) | Grant | |
Chief Financial Officer
|
Jan 29, 2025 | 19,598 | $0 | 648,228 (+3.0%) | Grant | |
Evp, Sales
|
Jan 29, 2025 | 21,106 | $0 | 771,330 (+2.7%) | Grant | |
CEO
|
Jan 21, 2025 | 6,687 | $80,244 | 5,501,715 (-0.1%) | Sale | |
Evp, Sales
|
Jan 13, 2025 | 58,283 | $624,211 | 502,311 (-11.6%) | Sale | |
Evp, Sales
|
Jan 10, 2025 | 238 | $2,380 | 560,594 (-0.0%) | Sale | |
Dec 18, 2024 | 126,051 | $0 | 414,492 (+30.4%) | Grant | ||
Evp, Sales
|
Dec 11, 2024 | 62,018 | $600,954 | 560,832 (-11.1%) | Sale | |
Evp, People Culture
|
Dec 10, 2024 | 23,157 | $223,465 | 1,276,206 (-1.8%) | Payment of Exercise Price | |
Evp, People Culture
|
Dec 10, 2024 | 36,301 | $97,650 | 1,224,745 (+3.0%) | Exercise/Conversion | |
Evp, People Culture
|
Dec 10, 2024 | 1,866 | $3,601 | 1,226,611 (+0.2%) | Exercise/Conversion | |
Evp, People Culture
|
Dec 10, 2024 | 72,752 | $122,223 | 1,299,363 (+5.6%) | Exercise/Conversion | |
CEO
|
Nov 21, 2024 | 50,000 | $504,500 | 5,508,402 (-0.9%) | Sale | |
CEO
|
Nov 20, 2024 | 50,000 | $501,500 | 5,558,402 (-0.9%) | Sale | |
Aug 23, 2024 | 35,000 | $201,600 | 50,000 (+70.0%) | Purchase | ||
Aug 23, 2024 | 16,978 | $100,000 | 331,696 (+5.1%) | Purchase | ||
Aug 22, 2024 | 8,818 | $49,998 | 314,718 (+2.8%) | Purchase | ||
Aug 21, 2024 | 50,000 | $283,500 | 288,441 (+17.3%) | Purchase |